The story of copyright's flagship drug presents a nuanced case for stakeholders in the drug sector. While initially a phenomenal success, creating vast sums, the patent expiration and the subsequent entry of off-brand https://escort546840.blogdomago.com/40243954/the-little-copyright-and-big-pharma-a-risky-investment